Status:
COMPLETED
Effect of Medically-tailored Meal Delivery Service on Changes in Hemoglobin A1c (HbA1c) in Patients With Diabetes
Lead Sponsor:
Mayo Clinic
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of medically-tailored meal delivery (10 meals per week for 3 months) on glycemic control in diabetic patients.
Eligibility Criteria
Inclusion
- Adult men and women with non-insulin dependent diabetes.
- Ages 25 to 75 years.
- Fasting blood sugar of greater than 140 mg/dl, on no oral hypoglycemic agents and a hemoglobin A1C less than 13%.
- Stabilized patients on oral hypoglycemic agents for one month or longer prior to starting the study and a hemoglobin A1C between 7.5% - 13%.
Exclusion
- Insulin use.
- Substance abuse.
- Any documented medical problem that would inhibit full participation in the study.
- BMI less than 25 or great than 40.
- Vegans or Vegetarians
- Individuals with food allergies.
- Individuals currently on a commercial weight loss or diet program.
Key Trial Info
Start Date :
August 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2021
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04523155
Start Date
August 24 2020
End Date
June 4 2021
Last Update
July 12 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
2
Mayo Clinic
Jacksonville, Florida, United States, 32224